You are here » Home » Companies » Company Overview » ACE Laboratories Ltd

ACE Laboratories Ltd.

BSE: 526077 Sector: Health care
NSE: ACELAB ISIN Code: N.A.
BSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
NSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
OPEN
PREVIOUS CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr)
Buy Price
Buy Qty
Sell Price
Sell Qty
OPEN
CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr)
Buy Price
Buy Qty
Sell Price
Sell Qty

ACE Laboratories Ltd. (ACELAB) - Company History

Promoted by Ajit Chand Srimal and Shailendra Tewari, Ace Laboratories (ALL) manufactures pharmaceutical formulations. It has diversified into bulk drugs such as ciprofloxacin and trimethoprim. It exports mainly to Europe, west Asia, the UK, Africa, Australia etc. ALL has signed MoUs with companies in west Asia, the UK and Nigeria, which will enable the registration of its products in these countries. These agreements will widen the overseas market to include Russia, South Africa and the Commonwealth of Independent States. ALL promoted Ace Diagnostics and Biotech in 1995 to manufacture and market medical diagnostic kits and reagents. ALL has undertaken a backward integration project to indigenously manufacture EMME and TOEF, two import-substitute products, and an expansion project to set up two formulation projects in Himachal Pradesh and Alwar. To further strenghten its R&D base, it plans to set up an integrated R&D centre at Alwar.

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard